September 22, 2022 Aprea Therapeutics Announces Poster Presentation at the 2022 Rivkin Center and American Association for Cancer (AACR) Virtual Ovarian Cancer Research Seminar Series
September 15, 2022 Aro Biotherapeutics Receives FDA Rare Pediatric Drug Designation for ABX1100 for the Treatment of Pompe Disease
September 12, 2022 Pretzel Therapeutics Launches With $72.5 Million Series A Financing to Pioneer Mitochondrial Therapies
September 12, 2022 Precirix enters into collaboration with Eckert & Ziegler for the development of its 68Ga-based compounds
September 07, 2022 Oncopeptides receives 5 MSEK grant for NK-cell engager project in multiple myeloma
September 04, 2022 CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/Emphysema